Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
SaleCommon Stock | 4,266 | $152.43 | $650,272.35 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · nonDerivative · entry 2 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,183 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. F2 · price: Reflects the weighted average price of 4,266 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $151.92 to $152.86 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:24 UTC |
HOLT VICTORIA MDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,990 | $67.15 | $1,208,028.50 |
DisclosureSEC source: 0001437749-20-019410 · rdgdoc.xml · nonDerivative · entry 1 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:33 UTC |
Goodman John BDirector
|
SaleCommon Stock | 1,000 | $132.75 | $132,746.40 |
DisclosureSEC source: 0001437749-20-018753 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,586 F1 · price: Reflects the weighted average price of 1,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 24, 2020 with sale prices ranging from $132.72 to $132.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2020 Filed Aug 12, 2020 20:13 UTC |
WEHRWEIN SVENDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 762 | $0.00 Strike: $30.58 | $0.00 |
DisclosureSEC source: 0001437749-20-017656 · rdgdoc.xml · derivative · entry 6 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 762 shares Expires 2022-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 12, 2020 Filed Aug 12, 2020 20:13 UTC |
WEHRWEIN SVENDirector
|
SaleCommon Stock | 762 | $131.00 | $99,822.00 |
DisclosureSEC source: 0001437749-20-017656 · rdgdoc.xml · nonDerivative · entry 4 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,386 Read SEC document |
| August 12, 2020 Filed Aug 12, 2020 20:13 UTC |
WEHRWEIN SVENDirector
|
Exercise / conversionCommon Stock | 762 | $30.58 | $23,301.96 |
DisclosureSEC source: 0001437749-20-017656 · rdgdoc.xml · nonDerivative · entry 3 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:13 UTC |
WEHRWEIN SVENDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $30.58 | $0.00 |
DisclosureSEC source: 0001437749-20-017656 · rdgdoc.xml · derivative · entry 5 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 762 Underlying: Common Stock · 4,000 shares Expires 2022-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:13 UTC |
WEHRWEIN SVENDirector
|
SaleCommon Stock | 4,000 | $130.05 | $520,213.20 |
DisclosureSEC source: 0001437749-20-017656 · rdgdoc.xml · nonDerivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,386 F1 · price: Reflects the weighted average price of 4,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 11, 2020 with sale prices ranging from $130.00 to $130.315 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:13 UTC |
WEHRWEIN SVENDirector
|
Exercise / conversionCommon Stock | 4,000 | $30.58 | $122,320.00 |
DisclosureSEC source: 0001437749-20-017656 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:17 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,608 | $0.00 Strike: $62.90 | $0.00 |
DisclosureSEC source: 0001437749-20-017341 · rdgdoc.xml · derivative · entry 9 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,608 shares Expires 2024-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:17 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,348 | $0.00 Strike: $57.88 | $0.00 |
DisclosureSEC source: 0001437749-20-017341 · rdgdoc.xml · derivative · entry 8 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,837 Underlying: Common Stock · 8,348 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2017. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:17 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,995 | $0.00 Strike: $67.15 | $0.00 |
DisclosureSEC source: 0001437749-20-017341 · rdgdoc.xml · derivative · entry 7 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,995 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:17 UTC |
WAY JOHNChief Financial Officer
|
SaleCommon Stock | 200 | $133.66 | $26,731.00 |
DisclosureSEC source: 0001437749-20-017341 · rdgdoc.xml · nonDerivative · entry 6 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,150 F3 · price: Reflects the weighted average price of 200 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 6, 2020 with sale prices ranging from $133.37 to $133.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:17 UTC |
WAY JOHNChief Financial Officer
|
SaleCommon Stock | 2,050 | $132.53 | $271,683.43 |
DisclosureSEC source: 0001437749-20-017341 · rdgdoc.xml · nonDerivative · entry 5 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,350 F2 · price: Reflects the weighted average price of 2,050 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 6, 2020 with sale prices ranging from $132.15 to $133.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:17 UTC |
WAY JOHNChief Financial Officer
|
SaleCommon Stock | 13,701 | $131.44 | $1,800,830.67 |
DisclosureSEC source: 0001437749-20-017341 · rdgdoc.xml · nonDerivative · entry 4 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,400 F1 · price: Reflects the weighted average price of 13,701 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 6, 2020 with sale prices ranging from $131.14 to $132.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:17 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionCommon Stock | 2,608 | $62.90 | $164,043.20 |
DisclosureSEC source: 0001437749-20-017341 · rdgdoc.xml · nonDerivative · entry 3 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:17 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionCommon Stock | 8,348 | $57.88 | $483,182.24 |
DisclosureSEC source: 0001437749-20-017341 · rdgdoc.xml · nonDerivative · entry 2 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:17 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionCommon Stock | 4,995 | $67.15 | $335,414.25 |
DisclosureSEC source: 0001437749-20-017341 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:56 UTC |
Black Archie C.Director
|
GrantCommon Stock | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011583 · rdgdoc.xml · nonDerivative · entry 1 Black Archie C. · CIK 0001489095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,309 F1 · shares: The deferred stock units vest in full on May 19, 2021, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:55 UTC |
Chand SujeetDirector
|
GrantCommon Stock | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011582 · rdgdoc.xml · nonDerivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,744 F1 · shares: The deferred stock units vest in full on May 19, 2021, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:55 UTC |
Chin MoonhieDirector
|
GrantCommon Stock | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011581 · rdgdoc.xml · nonDerivative · entry 1 Chin Moonhie · CIK 0001395001 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,187 F1 · shares: The deferred stock units vest in full on May 19, 2021, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:54 UTC |
Gawlick RainerDirector
|
GrantCommon Stock | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011580 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,259 F1 · shares: The deferred stock units vest in full on May 19, 2021, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:53 UTC |
Goodman John BDirector
|
GrantCommon Stock | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011579 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,586 F1 · shares: The deferred stock units vest in full on May 19, 2021, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:51 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011577 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,386 F1 · shares: The deferred stock units vest in full on May 19, 2021, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:52 UTC |
KRANTZ DONALD GDirector
|
GrantCommon Stock | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011578 · rdgdoc.xml · nonDerivative · entry 1 KRANTZ DONALD G · CIK 0001183159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,744 F1 · shares: The restricted stock units vest in full on the earlier of May 19, 2021 or the date of the Company's 2021 annual meeting of shareholders. Read SEC document |
| May 18, 2020 Filed May 20, 2020 21:07 UTC |
Baker Arthur R. IIIChief Technology Officer
|
SaleCommon Stock | 1,988 | $115.07 | $228,751.21 |
DisclosureSEC source: 0001437749-20-011432 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,863 F1 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 258 shares purchased on May 15, 2020 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:22 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Tax withholdingCommon Stock | 252 | $94.22 | $23,743.44 |
DisclosureSEC source: 0001437749-20-009601 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,593 Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:10 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 3,773 | $109.00 | $411,257.00 |
DisclosureSEC source: 0001437749-20-009262 · rdgdoc.xml · nonDerivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,223 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:10 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 3,118 | $107.00 | $333,626.00 |
DisclosureSEC source: 0001437749-20-009262 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,996 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:10 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 2,790 | $101.85 | $284,161.50 |
DisclosureSEC source: 0001437749-20-009262 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,114 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 21:41 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,381 | $0.00 Strike: $30.58 | $0.00 |
DisclosureSEC source: 0001437749-20-007787 · rdgdoc.xml · derivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,381 shares Expires 2022-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 21:41 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 2,381 | $30.58 | $72,810.98 |
DisclosureSEC source: 0001437749-20-007787 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:30 UTC |
HOLT VICTORIA MDirector · President and CEO
|
Tax withholdingCommon Stock | 3,244 | $78.16 | $253,551.04 |
DisclosureSEC source: 0001437749-20-004815 · rdgdoc.xml · nonDerivative · entry 2 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,459 F2 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of PSUs. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:30 UTC |
HOLT VICTORIA MDirector · President and CEO
|
GrantCommon Stock | 7,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-004815 · rdgdoc.xml · nonDerivative · entry 1 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,703 F1 · shares: On February 13, 2017, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019. As determined on March 9, 2020, based on actual performance for 2019, the reporting person vested 7,113 PSUs of the 25,707 PSUs originally granted. The remaining 18,594 shares were forfeited. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:21 UTC |
HOLT VICTORIA MDirector · President and CEO
|
Tax withholdingCommon Stock | 2,642 | $100.00 | $264,200.00 |
DisclosureSEC source: 0001437749-20-002914 · rdgdoc.xml · nonDerivative · entry 1 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,590 Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:20 UTC |
WAY JOHNChief Financial Officer
|
Tax withholdingCommon Stock | 1,756 | $100.00 | $175,600.00 |
DisclosureSEC source: 0001437749-20-002911 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,150 Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:24 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Tax withholdingCommon Stock | 838 | $100.00 | $83,800.00 |
DisclosureSEC source: 0001437749-20-002920 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,845 Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:22 UTC |
Bodor RobertVP/General Manager-Americas
|
Tax withholdingCommon Stock | 1,245 | $100.00 | $124,500.00 |
DisclosureSEC source: 0001437749-20-002917 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,904 Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:18 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
Tax withholdingCommon Stock | 212 | $100.00 | $21,200.00 |
DisclosureSEC source: 0001437749-20-002909 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,063 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:33 UTC |
HOLT VICTORIA MDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,187 | $0.00 Strike: $96.72 | $0.00 |
DisclosureSEC source: 0001437749-20-002466 · rdgdoc.xml · derivative · entry 2 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,187 Underlying: Common Stock · 10,187 shares Expires 2030-02-10 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:33 UTC |
HOLT VICTORIA MDirector · President and CEO
|
GrantCommon Stock | 8,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-002466 · rdgdoc.xml · nonDerivative · entry 1 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,232 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:32 UTC |
WAY JOHNChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,501 | $0.00 Strike: $96.72 | $0.00 |
DisclosureSEC source: 0001437749-20-002464 · rdgdoc.xml · derivative · entry 2 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,501 Underlying: Common Stock · 5,501 shares Expires 2030-02-10 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:32 UTC |
WAY JOHNChief Financial Officer
|
GrantCommon Stock | 4,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-002464 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,906 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:30 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,445 | $0.00 Strike: $96.72 | $0.00 |
DisclosureSEC source: 0001437749-20-002461 · rdgdoc.xml · derivative · entry 2 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,445 Underlying: Common Stock · 2,445 shares Expires 2030-02-10 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:30 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
GrantCommon Stock | 2,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-002461 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,275 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:30 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,668 | $0.00 Strike: $96.72 | $0.00 |
DisclosureSEC source: 0001437749-20-002460 · rdgdoc.xml · derivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,668 Underlying: Common Stock · 3,668 shares Expires 2030-02-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:30 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantCommon Stock | 3,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-002460 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,683 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2021. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 291 shares purchased on May 15, 2018, 197 shares purchased on May 15, 2019, and 1 share purchased on November 15, 2019 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,668 | $0.00 Strike: $96.72 | $0.00 |
DisclosureSEC source: 0001437749-20-002456 · rdgdoc.xml · derivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,668 Underlying: Common Stock · 3,668 shares Expires 2030-02-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantCommon Stock | 3,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-002456 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,149 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2021. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 241 shares purchased on May 15, 2018, 55 shares purchased on November 15, 2018, 197 shares purchased on May 15, 2019, and 1 share purchased on November 15, 2019 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 21:31 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
Tax withholdingCommon Stock | 477 | $95.83 | $45,710.91 |
DisclosureSEC source: 0001437749-19-023808 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,227 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.